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Short-bowel syndrome is responsible for significant metabolic alterations that compromise nutritional status. Glutamine
is considered an essential nutrient for enterocytes, so beneficial effects from supplementation of the diet with glutamine are
hypothesized.
PURPOSE: In this study, the effect of a diet enriched with glutamine was evaluated in rats undergoing extensive small
bowel resection, with analysis of postoperative weight loss and intestinal morphometrics of villi height, crypt depth, and
thickness of the duodenal and remnant jejunal mucosa.
METHODS: Three groups of male Wistar rats were established receiving the following diets: with glutamine, without
glutamine, and the standard diet of laboratory ration. All animals underwent an extensive small bowel resection, including
the ileocecal valve, leaving a remnant jejunum of only 25 cm from the pylorus that was anastomosed lateral-laterally to the
ascendant colon. The animals were weighed at the beginning and end of the experiment (20th postoperative day). Then they
were killed and the remnant intestine was removed. Fragments of duodenal and jejunal mucosa were collected from the
remnant intestine and submitted to histopathologic exam. The morphometric study of the intestinal mucosa was accomplished
using a digital system (KS 300) connected to an optic microscope. Morphometrics included villi height, crypt depth, and
the total thickness of intestinal mucosa.
RESULTS: The weight loss comparison among the 3 groups showed no significant loss difference. The morphometric
studies showed significantly taller duodenal villi in the glutamine group in comparison to the without glutamine group, but
not different from the standard diet group. The measurements obtained comparing the 3 groups for villi height, crypt depth,
and thickness of the remnant jejunum mucosa were greater in the glutamine-enriched diet group than for the without-
glutamine diet group, though not significantly different from with standard-diet group.
CONCLUSIONS: In rats with experimentally produced short-bowel syndrome, glutamine-enrichment of an
isonitrogenous test diet was associated with an improved adaptation response by the intestinal mucosa but not reduced
weight loss. However, the adaptation response in the group receiving the glutamine-enriched diet was not improved over
that for the group fed regular chow.
KEYWORDS: Glutamine. Short-bowel syndrome. Intestinal mucosa.
Short-bowel syndrome (SBS) oc-
curs after massive intestinal resection
in the treatment of inflammatory dis-
eases, volvulus, abdominal trauma,
mesenteric ischemia, and other afflic-
tions. It causes significant metabolic
alterations of lipids,1 insulin, fatty ac-
ids, hepatic glycogen, and glycemia2
that in the long term influence the
prognosis of the patient .3 In these pa-
tients, the intestinal absorption of nu-
trients depends on many factors, such
as the extent of the resected segment;
the presence of ileocecal valve; the
function of the colon, stomach, pan-
creas, liver, and remnant small bowel;
and adaptive changes of the
gastrointestinal tract.4
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Glutamine comprises almost 20% of
the amino acids found in the blood
stream, almost twice as much as alanine.5
Its plasma concentration reduces during
catabolic conditions.6 Classified as a
nonessential amino acid because of be-
ing synthesized in various tissues from
glutamate, it is considered a primary nu-
trient required by the enterocytes
for their growth and energetic
substrate.7,8,9,10,11 Glutamine also plays an
important role in nitrogen transport
among tissues,12 regulating protein and
amino acid synthesis, and is an impor-
tant precursor for renal ammoniagenesis
as well as for lipid9, nucleotide, and
alanine synthesis.2,6 Glutamine, when in-
troduced into portal hepatic circulation,
is used as a substrate for ureagenesis and
glucogenesis.5,8
Beneficial effects of exogenous
glutamine have been observed in pa-
tients in catabolic conditions, includ-
ing surgical stress, sepsis,13 bone mar-
row transplants,10 immune suppressor
treatments, and burnings;2 these effects
include the preservation of the mu-
cosal integrity and the prevention of
translocation of bacteria and toxins.10
The mechanisms and mediators of
intestinal adaptation are multifactorial.
Among them, luminal nutrition11,14,15,
pancreaticobiliary secretion, various
hormones,15 and growth factors16 play
important roles.
Patients with SBS can cease need-
ing parenteral nutrition through com-
pensatory mechanisms that can last up
to 2 years.17 Various hormones, such as
growth hormone,17 glucagon-like pep-
tide 2,18 and epidermal growth factor,
have been used to improve intestinal
trophism in SBS.9 Glutamine supple-
mentation has been used in clinical
and experimental situations of trophic
reduction and intestinal absorption
damage, although its real efficiency
has not yet been proved.20—22 When as-
sociated with growth hormone,
glutamine supplementation has been
shown to have a gut-trophic effect and
to enhance intestinal absorption, both
experimentally4,22 and in clinical stud-
ies.17 However, other researchers have
not found considerable improvement
with the association of glutamine and
growth hormone.10,23
The main purpose of this study was
to compare the morphometry of the
mucosa of the intestinal remnant of
rats undergoing extensive intestinal
resection and fed with diets with and
without glutamine. Because of the as-
sociated weight loss that intestinal re-
section causes, the influence of differ-
ent diets on the weight of the animals
was also analyzed.
OBJECTIVES
1) To evaluate the influence of a
glutamine-enriched diet on the mor-
phometry of the mucosa of remnant in-
testines of rats undergoing massive in-
testinal resection.
2) To analyze the effect of a
glutamine-enriched diet on weight
loss in these animals after resection.
MATERIALS AND METHODS
Twenty-five Wistar adult male rats
(Rattus norvegicus albinus) that were
6 months old, with weights ranging
from 296 to 450 g (average, 341.9 g)
were used in the study. All animals un-
derwent a 3-day adaptation period, in-
cluding being accommodated in ap-
propriate cages.
After a 12-hour night fast, all ani-
mals were weighed (initial weight) and
anaesthetized with hydrochloride
ketamine (Ketalar®), IP, 0.2 mL/100 g,
for the massive intestinal resection. Af-
ter the surgery, the weight of the
resected bowel was subtracted from the
initial weight producing the weight af-
ter surgery (real initial weight).
Surgical technique. The abdomen
was opened by medial incision. The
surgical procedure consisted of partial
resection of jejunum and the entire il-
eum including the ileocecal valve and
1 cm of the proximal colon, conserving
25 cm of proximal jejunum in all prepa-
rations. The resulting stomas were
closed with continuous suturing with 6-
0 monofilament nylon. Then jejunum-
colon anastomosis was accomplished
lateral-laterally with a length of 1 cm,
with continuous suturing with 6-0
monofilament nylon. After surgery, the
animals (separated by transparent par-
tition walls) were kept in cages with the
capacity for 5 animals and were pro-
vided water and food ad libitum.
Diets. The diet without glutamine
was composed of soy oil (16.5 g),
maize starch (162.5 g) and calcium ca-
seinate (55.5 g). The glutamine-en-
riched diet (12%) contained soy oil
(16.5 g), maize starch (162.5 g), cal-
cium caseinate (28 g), and glutamine
(25 g). These diets contained equal
numbers of calories and grams of pro-
tein, with approximately 994.4 calo-
ries, supplying 4.36 calories per gram.
The grams of amino acids in the diets
with and without glutamine in 50 g of
protein are listed in Table 1. The
Nuvilab® ration consisted of amino ac-
ids, vitamins (A, D3, K3, B1, B2, B6,
B12, niacin, pantothenic acid, folic
acid, biotin, and choline), and miner-
als (iron, zinc, manganese, selenium,
and cobalt).
The animals were randomly di-
vided into 3 groups as follows:
EwG Group (enterectomized /
without glutamine)—Comprised 10
animals that underwent intestinal re-
section and that received the test oral
diet without glutamine.
EG Group (enterectomized / with
glutamine)—Comprised 10 animals
that underwent intestinal resection and
that received the test oral diet with
glutamine.
ER Group (enterectomized / ra-
tion)—Comprised 5 animals undergo-
ing intestinal resection and that re-
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ceived the conventional oral diet
(Nuvilab® ration).
The animals were observed for 20
days, were weighed (final weight), and
were then killed by sulphuric ether in-
halation; The abdomen was reopened,
and the stomach, duodenum, remnant
jejunum, colon, and liver were re-
moved. After being washed with saline
solution 0.9%, the excised tissues were
stored in buffered 10% formol solu-
tion for 3 days. Two longitudinal duo-
denum fragments of 1 cm were iso-
lated 2 to 4 cm from the pylorus as well
as another from the jejunum 2 to 10
cm from the anastomosis, encompass-
ing the entire thickness of the small
bowel wall. The material was sliced
into 5 m sections, which were stained
with hematoxylin and eosin.
For the morphometric study of intes-
tinal mucosa, Kontron Imaging System
software was used (Kontron Image
Analysis KS 300 program of Kontron
Elektronik Gmbh, Image Analysis Divi-
sion) in conjunction with a Zeiss micro-
scope fitted with a video camera. The
video camera transferred the image from
the microscope to the computer screen.
The height of each villus was manu-
ally delimited with a computer mouse
from its apex to the transition into the
crypt zone (Figure 1). The studied in-
testinal mucosa area comprised the en-
tire mucosal thickness from the apex of
the villus to the muscularis mucosae
(Figure 2). The measurements were ex-
pressed in microns. The analysis was
made under 100x magnification using
specimens in which the villi and the
crypts were perpendicular to the mus-
cularis mucosae.
The following measurements were
obtained:
- Villus height – from the top of the
villus to the villus-crypt junction
(Fig. 1).
- Total mucosal thickness – from the
top of the villus to the border over
the muscularis mucosae
- Crypt depth – represented by the
difference between the total mu-
cosal thickness and the villus
height.
Statistical Analysis
For the analysis of the different
values related to postsurgical weight
loss and to the measurements of villi
height, crypt depth, and total mucosal
thickness of the different groups, the
nonparametric Kruskal-Wallis test for
independent samples was used. For the
multiple comparisons, the Dunn test
was used. A significance level of 5%
(P =.05) was set.
RESULTS
The glutamine-enriched diet did
not affect the weight evolution of the
Figure 1 - Histology of a remnant jejunum, depicting the villus height measurement.
Table 1 – Amino acid content of the diets with and without glutamine in 50 g of
protein.
Amino acid Diet without glutamine Diet with glutamine
aspartic acid 3.33 1.66
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animals. No difference between the real
initial weight and the final weight
among the animals of the different
groups was observed (Table 2).
The results of the morphometric
study comparing the duodenal and
jejunal mucosa villi height, crypt
depth, and total mucosal thickness, of
the EwG, EG, and ER groups are
shown in Table 3. There was a statisti-
cally significant difference (P <.05) in
duodenal villi height, jejunal villi
height, jejunal crypt depth, and jejunal
mucosa thickness (Kruskal-Wallis
test). No difference between groups
was found for duodenal crypt depth
and duodenal mucosa thickness.
Applying the Dunn test to each of
the variables that were significantly
different, the following was observed:
1) the group that received the
glutamine-enriched diet (EG) had duo-
denal villi that were considerably
taller than the EwG group (P <.05) but
were similar to the ER group; 2) the
EG group had significantly taller
jejunal villi, increased jejunal crypt
Figure 2 - Histology of a remnant jejunum depicting the total mucosal thickness measurement.
Table 2 - Differences between the real initial and final weight loss expressed.
N Average(grams) Standard deviation
Enteral diet without glutamine 10 157.60 17.77
Enteral diet with glutamine 10 155.70 31.97
Regular enteral diet 0 5 121.80 26.72
P >.05
Table 3 - Enteral diet without glutamine (EwG), enteral diet with glutamine (EG), and regular enteral diet (ER) group
comparisons.
Variable Group n Average Standard Median Minimum Maximum P
(microns) deviation
Duodenal villi height EwG 10 528.7 55.2 518.2 442.1 608.9
EG 10 613.5 92.3 612.3 469.3 763.6 P <.05
ER 0 5 659.8 83.1 656.2 556.1 782.7
Duodenal crypt depth EwG 10 176.0 34.3 174.1 123.7 218.5
EG 10 198.1 49.2 186.7 114.8 289.0 P <.05
ER 0 5 174.6 38.4 180.2 134.8 231.6
Duodenal mucosa thickness EwG 10 704.7 80.8 706.1 570.0 826.7
EG 10 811.6 119.6 822.9 635.4 971.2 P <.05
ER 0 5 834.4 107.4 803.6 690.9 966.0
Jejunal villi height EwG 10 465.9 79.7 476.6 363.1 568.2
EG 10 641.8 112.4 651.5 361.7 778.8 P <.05
ER 0 5 620.8 138.3 622.3 477.8 798.3
Jejunal crypt depth EwG 10 154.3 47.9  144.4 97.2 239.1
EG 10 211.5 57.5 206.6 148.0 345.1 P <.05
ER 0 5 170.8 47.1 159.6 124.4 222.9
Jejunal mucosa thickness EwG 10 620.2 123.1 631.6 475.2 807.3
EG 10 853.2 140.7 871.5 510.9 981.6 P <.05
ER 0 5 791.7 184.0 781.9 602.2 1016.0
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depth, and thicker jejunal mucosa
when compared to the EwG group (P
<.05), but did not differ significantly
from the ER group.
DISCUSSION
Adaptation by and prognosis for
SBS patients depend on many factors
including patient age, extent and
height of the resected segment, pres-
ence of the ileocecal valve, presence
of the colon, and concomitant intesti-
nal diseases.24 Proximal small bowel
resection does not lead to large ab-
sorption changes, due to the absorption
capacity of the ileum,25 but it dimin-
ishes the secretion of intestinal hor-
mones, such as cholecystokinin and
the secretin.26 However, extirpation of
the ileum causes steatorrhea, due to
reduction in the pool of bile salts caus-
ing incomplete fat digestion, and
diarrhea, because of the cathartic effect
of the bile salts that are not absorbed
in the colonic mucosa. The presence
or absence of the ileocecal valve con-
tributes decisively to the intestinal
transit velocity. Its absence is related
to an increased velocity, in addition to
allowing bacterial colonization of the
small bowel, worsening the diarrheic
condition.25,27
In response to massive intestinal
resection, the remaining bowel devel-
ops significant adaptation mechanisms
to compensate the loss of mucosal sur-
face. Increases of caliber and thickness
of the intestinal wall and of absorption
and digestion capacity have been ob-
served. The compensatory mechanisms
are more intense in the ileum than in
the jejunum and reach their develop-
ment limit 4 weeks after intestinal re-
section.16
This adaptation phenomenon oc-
curs following intestinal resection
when nutrients are given orally, con-
sequently improving nutrient absorp-
tion, diminishing diarrhea, and even
reducing bacterial translocation. Adap-
tation has been shown to be enhanced
by proper nutritional orientation, use
of growth hormone, glucagon-like
hormone infusion, diets rich in fiber,
and glutamine (administered both
orally and parenterally), and other
measures.17,18,22,28
Supplemental glutamine usage has
been shown to have trophic benefits for
the intestinal mucosa in different clini-
cal and experimental situations, which
prompted its study in SBS.7,28,29,30
Yang et al. (2000), after administer-
ing 2 g/kg/day of glutamine by enteral
bolus to rats undergoing extensive in-
testinal resection, did not observe im-
provement in intestinal adaptation af-
ter the 10th day post surgery.31
Regarding the toxic effect of
cyclosporin on the intestinal epithe-
lium, Zhang et al. (1995) studied rats
undergoing small bowel transplant
while using immunosuppression with
cyclosporin (15 mg/kg). Animals re-
ceived either elemental diet with 2%
glutamine or the same diet with bal-
anced nonessential amino acids (with-
out glutamine). They observed reduc-
tion of bacterial translocation and in-
creased crypt depth and villi height of
the transplanted intestine in the
groups that had the glutamine-en-
riched diet.28
The study of malnourished rats by
Tannuri et al. (2000) found that the use
of oral diet supplemented with 2%
glutamine was significantly more effi-
cient in correcting the alterations of
the jejunal crypts than the control
regular diet, and the former also im-
proved trophism of intestinal mu-
cosa.30
Many experimental4,22 and clini-
cal32 studies have found beneficial ef-
fects in SBS when growth hormone was
associated with glutamine, showing it
improved the absorption and capacity
for adaptation of the remnant intestine.
An experimental protocol with rats
undergoing 85% resection of the small
bowel showed that animals receiving
a glutamine enriched diet and exog-
enous growth hormone had taller in-
testinal villi and thicker mucosae,
compared to those treated with either
in isolation. In fact, the glutamine en-
riched diet, per se, was not different
from controls receiving isocaloric
isonitrogenous diets, minus
glutamine.22 Thse data confirm a pre-
vious similar report. 27
Byrne et al. (1995) studied the ef-
fect of a carbohydrate-rich, low-fat diet
supplemented with glutamine and
growth hormone for 28 days followed
by supplementation with glutamine
alone in 47 adults with SBS. The pa-
tients in this study had an average
jejunal-ileal length of 50 cm and had
been dependent on parenteral nutrition
5 to 7 years.17 Isolated measures pro-
moted subtle improvement of intesti-
nal absorption, however, when growth
hormone and glutamine were used to-
gether, protein absorption increased
38% (P <.02) and the fecal volume
was reduced by one-third (P <.05).
Four weeks later, all patients had
gained weight, increased enteral nutri-
tion, and reduced intravenous liquids
and calories; 57% of patients ceased
needing parenteral nutrition while
30% reduced the need for parenteral
nutrition. Is was concluded that the in-
testinal function of patients with SBS
for a long period of time can improve
with a carbohydrate-rich, low-fat diet
supplemented with growth hormone
and glutamine.17
However, other researchers ob-
served no such improvement of the
fatty acid absorption or weight gain
when growth hormone and glutamine
were included in the SBS treatment.18
Similarly, an oral diet with glutamine,
low in fat, and rich in carbohydrates
did not positively affect intestinal
morphology, gastrointestinal transit, D-
xylose absorption, or loss of moist
weight of the feces in patients with
SBS.21
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Szkudlarek et al. (2000), in a dou-
ble-blind crossover study, analyzed the
effect of a high dose of growth hormone
associated with glutamine, administered
for 28 days, in 8 patients with SBS. At
the end of the treatment, improvement
of absorption of carbohydrates, fat, and
nitrogen was not observed.23
The enterectomized animals in this
study that received the glutamine-en-
riched diet (EG group) had taller
jejunal villi, deeper jejunal crypts, and
thicker jejunal mucosa compared to
the group that received the diet with-
out glutamine. However, the results for
the EG group were similar to those ob-
tained in the animals that received
usual ration. It is possible that animals
given the glutamine-enriched diet,
which was isonitrogenous with the
control diet, became protein deficient
in comparison to those receiving the
usual ration. To avoid this, most au-
thors recommend adding glutamine to
the study group diet and a
nonimmuno-stimulating amino acid,
such as glycine, to the control group
diet. Finally, enterectomized rats that
received a glutamine-enriched diet
presented a better adaptation of the in-
testinal mucosa when compared to the
enterectomized rats that received the
same diet without glutamine.
CONCLUSIONS
In rats with experimentally pro-
duced short-bowel syndrome,
glutamine-enrichment of an
isonitrogenous test diet was associated
with an improved adaptation response
by the intestinal mucosa but not re-
duced weight loss. However, the adap-
tation response in the group receiving
the glutamine-enriched diet was not
improved over that for the group fed
regular chow.
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RESUMO
RIBEIRO SR e col. Perda de peso e es-
tudo morfométrico da mucosa in-
testinal de ratos submetidos à
ressecção subtotal de intestino del-
gado. Influência do uso de dieta
com glutamina. Rev. Hosp. Clín.
Fac. Med. S. Paulo 59(6):349-356,
2004.
A síndrome do intestino curto é
responsável por alterações metabólicas
que comprometem o estado nutricional
do paciente. A glutamina é nutriente
essencial para os enterócitos.
OBJETIVOS: Estudou-se o efeito
da administração de dieta com gluta-
mina, em ratos submetidos à ressecção
subtotal do intestino delgado, avalian-
do a perda de peso pós-operatória e a
morfometria da mucosa intestinal.
MÉTODOS: Foram constituídos
três grupos de ratos Wistar machos re-
cebendo as seguintes dietas: com
glutamina (grupo EG), sem glutamina
(grupo EsG), e a dieta padrão do labo-
ratório (grupo ER). A ressecção intes-
tinal foi realizada em todos os animais
incluindo-se a válvula íleo-cecal, com
remanescente jejunal de apenas 25cm
a partir do piloro, anastomosado
látero-lateralmente ao cólon ascenden-
te. A diferença entre o peso inicial real
e ao final do experimento no 20º dia
pós-operatório foi registrada antes do
sacrifício. Fragmentos de mucosa do
duodeno e jejuno foram colhidos e co-
rados com hematoxilina-eosina. Rea-
lizou-se o estudo morfométrico da
mucosa intestinal, por meio de siste-
ma digital associado ao microscópio
ótico. Mediu-se a altura das vilo-
sidades, a profundidade das criptas e
a extensão total da mucosa intestinal.
RESULTADOS: A perda de peso
entre os três grupos não diferiu esta-
tisticamente. A análise da morfometria
da mucosa intestinal mostrou diferen-
ça significativa: 1) animais do grupo
Enterectomia com Glutamina (EG)
apresentaram vilosidade duodenal sig-
nificativamente maior que o grupo
EsG (p< 0,05), mas não diferiram do
grupo que recebeu dieta padrão do la-
boratório (ER); 2) nas medidas da
vilosidade jejunal, cripta jejunal e
mucosa jejunal, o grupo Enterectomia
com Glutamina (EG) apresentaram
maior altura, profundidade e extensão,
respectivamente, em relação ao grupo
Enterectomia sem glutamina (EsG)
(p<0,05), porém não diferiu estatistica-
mente do grupo dieta padrão do labo-
ratório (ER).
CONCLUSÕES: A oferta de dieta
oral acrescida de glutamina não con-
tribui para reduzir a perda de peso dos
animais submetidos à ressecção intes-
tinal extensa, em comparação a dieta
padrão, mas apresentou melhor efeito
na adaptação intestinal.
UNITERMOS: Glutamina. Síndro-
me do Intestino Curto. Mucosa intes-
tinal.
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